Bausch Health Companies Inc.
BHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,966,080 | $2,930,765 | $2,273,360 | $9,909,229 |
| - Cash | $1,181,000 | $947,000 | $564,000 | $582,000 |
| + Debt | $21,839,000 | $22,388,000 | $20,766,000 | $22,654,000 |
| Enterprise Value | $23,624,080 | $24,371,765 | $22,475,360 | $31,981,229 |
| Revenue | $9,625,000 | $8,757,000 | $8,124,000 | $8,434,000 |
| % Growth | 9.9% | 7.8% | -3.7% | – |
| Gross Profit | $6,843,000 | $6,198,000 | $5,760,000 | $6,040,000 |
| % Margin | 71.1% | 70.8% | 70.9% | 71.6% |
| EBITDA | $3,134,000 | $2,885,000 | $2,878,000 | $3,260,000 |
| % Margin | 32.6% | 32.9% | 35.4% | 38.7% |
| Net Income | -$46,000 | -$592,000 | -$225,000 | -$948,000 |
| % Margin | -0.5% | -6.8% | -2.8% | -11.2% |
| EPS Diluted | -0.13 | -1.62 | -0.59 | -2.61 |
| % Growth | 92% | -174.6% | 77.4% | – |
| Operating Cash Flow | $1,597,000 | $1,032,000 | -$728,000 | $1,426,000 |
| Capital Expenditures | -$337,000 | -$272,000 | -$268,000 | -$283,000 |
| Free Cash Flow | $1,260,000 | $760,000 | -$996,000 | $1,143,000 |